The microbiome and the gut-lung axis in tuberculosis: interplay in the course of disease and treatment
10.3389/fmicb.2023.1237998 · doi-reference
The roles of miRNA, lncRNA and circRNA in the development of osteoporosis
10.1186/s40659-020-00309-z · doi-reference
Screening and identification of differentially expressed long non-coding RNAs in multidrug-resistant tuberculosis
10.7717/peerj.12776 · doi-reference
Common variants at 11p13 are associated with susceptibility to tuberculosis
10.1038/ng.1080 · doi-reference
Long non-coding RNAs: From disease code to drug role
10.1016/j.apsb.2020.10.001 · doi-reference
Diagnosis of pulmonary tuberculosis in a microbiological laboratory
10.1016/j.medmal.2011.07.012 · doi-reference
Management of active tuberculosis in adults with HIV
10.1016/s2352-3018(19)30154-7 · doi-reference
Non-Coding RNAs in the Etiology and Control of Major and Neglected Human Tropical Diseases
10.3389/fimmu.2021.703936 · doi-reference
Antituberculosis Drug-Induced Adverse Events in the Liver, Kidneys, and Blood: Clinical Profiles and Pharmacogenetic Predictors
10.1002/cpt.924 · doi-reference
Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis
10.1053/jhep.2003.50144 · doi-reference
Safety of 3 Different Reintroduction Regimens of Antituberculosis Drugs after Development of Antituberculosis Treatment–Induced Hepatotoxicity
10.1086/650576 · doi-reference
Genetic polymorphisms of long noncoding RNA RP11-37B2.1 associate with susceptibility of tuberculosis and adverse events of antituberculosis drugs in west China
10.1002/jcla.22880 · doi-reference
RIPK2 polymorphisms and susceptibility to tuberculosis in a Western Chinese Han population
10.1016/j.meegid.2019.103950 · doi-reference
Clinical relevance of the lnc-HNF1B-3:1 genetic polymorphisms in Western Chinese tuberculosis patients
10.1002/jcla.23076 · doi-reference
Significance of genetic polymorphisms in long non-coding RNA AC079767.4 in tuberculosis susceptibility and clinical phenotype in Western Chinese Han population
10.1038/s41598-017-01163-y · doi-reference
Susceptibility to tuberculosis is associated with variants in the ASAP1 gene encoding a regulator of dendritic cell migration
10.1038/ng.3248 · doi-reference
Exosomes as mediators of intercellular crosstalk in metabolism
10.1016/j.cmet.2021.08.006 · doi-reference
The biology, function, and biomedical applications of exosomes
10.1126/science.aau6977 · doi-reference
Engineering exosomes for targeted drug delivery
10.7150/thno.52570 · doi-reference
Exosomes: key players in cancer and potential therapeutic strategy
10.1038/s41392-020-00261-0 · doi-reference
Serologic diagnosis of tuberculosis by combining Ig classes against selected mycobacterial targets
10.1016/j.jinf.2014.05.014 · doi-reference
Plasma and urine biomarkers in chronic kidney disease: closer to clinical application
10.1097/mnh.0000000000000735 · doi-reference
An Update on the Diagnosis of Tuberculosis Infection
10.1164/rccm.200509-1516pp · doi-reference
Cell therapy for peripheral artery disease
10.1016/j.coph.2018.01.005 · doi-reference
Comparison of media for a human peripheral blood mononuclear cell-based in vitro vaccine evaluation system
10.7774/cevr.2023.12.4.328 · doi-reference
Extensively drug-resistant tuberculosis
10.1016/s1473-3099(08)70260-3 · doi-reference
Tuberculosis prevention: current strategies and future directions
10.1016/j.cmi.2023.10.023 · doi-reference
Long non-coding RNAs in the regulation of the immune response
10.1016/j.it.2014.07.005 · doi-reference
LncRNAs in adaptive immunity: role in physiological and pathological conditions
10.1080/15476286.2020.1838783 · doi-reference
Epigenetics in Tuberculosis: Immunomodulation of Host Immune Response
10.3390/vaccines10101740 · doi-reference
B Cell-Directed Therapy in Autoimmunity
10.1146/annurev-immunol-083122-044829 · doi-reference
Pharmacological Inhibition of Host Heme Oxygenase-1 Suppresses Mycobacterium tuberculosis Infection In Vivo by a Mechanism Dependent on T Lymphocytes. Bloom BR
10.1128/mbio.01675-16 · doi-reference
Mycobacterium tuberculosis produces D-serine under hypoxia to limit CD8+ T cell-dependent immunity in mice
10.1038/s41564-024-01701-1 · doi-reference
CD8 + T Cells in Tuberculosis
10.1164/rccm.2204027 · doi-reference
Mycobacterium tuberculosis RpfB drives Th1-type T cell immunity via a TLR4-dependent activation of dendritic cells
10.1189/jlb.0912435 · doi-reference
Immunopathology in human tuberculosis
10.1126/sciimmunol.ado5951 · doi-reference
T cells and adaptive immunity to Mycobacterium tuberculosis in humans
10.1111/imr.12274 · doi-reference
Regulatory T cells turn pathogenic
10.1038/cmi.2015.12 · doi-reference
Immunology of Tuberculosis
10.1146/annurev.immunol.19.1.93 · doi-reference
Lnc-EST12, which is negatively regulated by mycobacterial EST12, suppresses antimycobacterial innate immunity through its interaction with FUBP3
10.1038/s41423-022-00878-x · doi-reference
